ArticleTherapeutic advances in gastroenterology2022
Ustekinumab is associated with superior treatment persistence but not with higher remission rates
Péter Bacsur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it